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Abstract: The aim of this work was the preparation and
characterization of scaffolds with mechanical and functional
properties able to regenerate bone. Porous scaffolds made of
chitosan/gelatin (POL) blends containing different amounts of
a bioactive glass (CEL2), as inorganic material stimulating bio-
mineralization, were fabricated by freeze-drying. Foams with
different compositions (CEL2/POL 0/100; 40/60; 70/30 wt %/wt)
were prepared. Samples were crosslinked using genipin (GP)
to improve mechanical strength and thermal stability. The
scaffolds were characterized in terms of their stability in water,
chemical structure, morphology, bioactivity, and mechanical
behavior. Moreover, MG63 osteoblast-like cells and periosteal-
derived stem cells were used to assess their biocompatibility.
CEL2/POL samples showed interconnected pores having an
average diameter ranging from 179 6 5 lm for CEL2/POL 0/
100 to 136 6 5 lm for CEL2/POL 70/30. GP-crosslinking and
the increase of CEL2 amount stabilized the composites to
water solution (shown by swelling tests). In addition, the SBF
soaking experiment showed a good bioactivity of the scaffold
with 30 and 70 wt % CEL2. The compressive modulus increased
by increasing CEL2 amount up to 2.1 6 0.1 MPa for CEL2/POL
70/30. Dynamical mechanical analysis has evidenced that com-
posite scaffolds at low frequencies showed an increase of stor-
age and loss modulus with increasing frequency; furthermore,
a drop of E0 and E00 at 1 Hz was observed, and for higher fre-
quencies both moduli increased again. Cells displayed a good
ability to interact with the different tested scaffolds which did
not modify cell metabolic activity at the analyzed points. MTT
test proved only a slight difference between the two cytotypes
analyzed. VC 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:
100A: 2654–2667, 2012.
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INTRODUCTION
The development of regenerative bone graft substitutes and
bone tissue engineering scaffolds is an important area in
the ﬁeld of biomaterials and orthopedics, in a busy scenario
for academia, industry, and clinicians, especially since sev-
eral commercial bone graft substitute products were suc-
cessfully applied in the clinics.1 The strategy of designing
scaffolds able to regenerate bone with good mechanical and
functional properties is a promising alternative to the use of
allografts, autografts, and metals. Scaffolds for bone repair
should be based on biomaterials with adequate properties
such as biocompatibility, osteoconduction, bioactivity,
osteoinduction, and biodegradation.2 Bone regeneration usu-
ally employs three-dimensional (3D) porous materials. The
3D porous structure provides the necessary support for
cells to proliferate and maintain their differential function,
and its architecture deﬁnes the ultimate shape of new
bone.3 Moreover, scaffolds for bone regeneration should
mimic bone morphology, structure, and function. Bone is
composed of calcium phosphate (69–80 wt %, mainly hy-
droxyapatite), collagen (17–20 wt %), and other compo-
nents (water, proteins, etc.).4 For this reason, composites
based on apatite crystals and natural polymers have
received increasing attention in bone tissue engineering
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applications due to their ability to preserve the structural
and biological phenotype of the damaged hard tissues in a
biomimetic way.5 3D sponge-like composite scaffolds based
on bioactive glass and a genipin-crosslinked network of chi-
tosan/gelatin were obtained by freeze-drying and investi-
gated, having a similar composition to that of natural bone.
Bioactive glasses are formed of different compositions of
SiO2 with the addition of Na2O, CaO, and P2O5; they react
with physiological ﬂuids and form strong chemical bonds
with the native tissue.6,7 Bioactive glasses have successfully
served as skeletal substitutes and to ﬁll bone defects in the
oral cavity, largely because of their osteoconductive proper-
ties.8,9 To retain these materials in a local defect site, bioac-
tive glasses have been incorporated into composites with
synthetic polymers for improved delivery and degrada-
tion.10,11 While most osteoconductive biomaterials predomi-
nantly serve as a passive site for cellular adhesion, prolifera-
tion, and differentiation, recent reports have demonstrated
that bioactive glasses may play a more active role in direct-
ing cellular behavior.12,13 BioglassV
R
45S5 has exhibited the
potential to support the growth of osteoblasts and their pre-
cursors in vitro and to favor osteoblast differentiation by
stimulating the synthesis of phenotypic markers such as
alkaline phosphatase, Type I collagen, and osteocalcin.13–15
Moreover, chitosan, a naturally derived polysaccharide, was
used as organic component of the composite scaffold. It has
gained much attention as a biomaterial in diverse tissue en-
gineering applications due to its low cost, large-scale avail-
ability, anti-microbial activity, and biocompatibility.16 Chito-
san ﬁlms are highly brittle with a strain at break of
40–50% in the wet state, while chitosan scaffolds with vari-
ous shapes, pore sizes, and pore orientation can be obtained
using freezing at a controlled-rate followed by lyophiliza-
tion.16 Furthermore, lysozyme-dependent chitosan degrada-
tion is inﬂuenced by the degree of deacetylation (DD),17
local pH,18 and homogeneity of the source; lysozymal hydro-
lysis is high in acidic conditions (pH ¼ 4.5–5.5)19 and
decreases with increasing DD. The mechanical or biological
properties of chitosan can be signiﬁcantly improved by
blending with other polymers.20 Gelatin, a nonexpensive
and commercially available biomaterial that has gained in-
terest in biomedical engineering, mainly because of its bio-
degradability, has been blended with chitosan to improve
the biological activity since (i) it contains Arg–Gly–Asp
(RGD)-like sequences that promote cell adhesion and migra-
tion, and (ii) it may form a polyelectrolyte complex with chi-
tosan. Gelatin–chitosan scaffold has been formed without or
with cross-linkers such as glutaraldehyde21 or enzymes,22
and tested for the regeneration of various tissues including
skin,23 cartilage,24 and bone.
The scaffolds were prepared by freeze-drying process
that is a conventional technique for the fabrication of po-
rous materials in which pore structure is controlled by the
ice crystal growth. Optimal pore diameters for 3D porous
structures for bone repair are in the 100–400 lm range.25
In this work, physical, chemical, and mechanical proper-
ties and the bioactivity of composite porous scaffold were
investigated. Moreover, to assess their biocompatibility and
possible use for the regeneration of osteochondral tissues,
the interaction with MG63 osteoblast-like cells and perios-
teal progenitor cells (PCs) was evaluated. The latter present
a cell-surface marker proﬁle similar to mesenchymal stem
cells (MSCs) that are prominent candidate cells to repair
complex skeletal tissue defects.26 MSCs, in fact, have a pro-
nounced expansion capacity, undergo no allogeneic rejection
after transplantation, and show a high plasticity. PCs also
have the potential to differentiate into bone, cartilage, fat,
and muscle27 and recent studies evaluating migration, hom-
ing, or engraftment potential of human PCs strengthened
the hypothesis of periosteum as an interesting cell source
for a bone tissue regenerative medicine.28
EXPERIMENTAL SECTION
Materials
Type A gelatin (CAS No. G2500-100G) from porcine skin
was supplied from Sigma, Italy. Chitosan derived from crab
shell with 76.5% deacetylation degree was purchased from
Sigma, Milan, Italy. The degree of deacetylation was deter-
mined by FT-IR spectroscopy using the following formula:29
%DD ¼ 100 ðA1320=A1420Þ  0:3822½ =0:03133 (1)
where A1320 is the absorbance at 1320 cm
–1, and A1420 is
the absorbance at 1420 cm–1.
Bioactive glass (CEL2, particle size < 30 lm) was pre-
pared according to a published procedure.30 Genipin (GP)
was purchased from Challenge Bioproducts, Taiwan. All sol-
vents used were of analytical grade and used without fur-
ther puriﬁcation.
Methods
Preparation of crosslinked CEL2/POL scaffolds. A 3% (w/
v) CH-G solution in 0.5M acetic acid (Sigma, Italy) was pre-
pared under stirring for 12 h at 40C. CH and G were mixed
at 1:2 weight ratio. CEL2 was added to the polymeric solu-
tion (POL) to obtain CEL2/POL composites with various
weight ratios between the components: 0/100; 40/60; 70/
30 (wt %/wt.). The composites were coded as follows:
CEL2/POL 0/100; 40/60; 70/30. For crosslinked samples,
GP was added to CEL2/POL solutions at deﬁned weight per-
centage (2.5 wt %/wt with respect to the gelatin/chitosan
amount). Each mixture was kept at 50C under stirring until
a gel started to form. The gel was spread on Petri dishes
(different sizes according to the speciﬁc tests) and freeze-
dried (Scanvac, CoolSafe) at –20C for 24 h to obtain porous
polymeric matrices. After freeze-drying, samples were
washed several times alternating 0.1N NaOH solution and
demineralized water to remove GP residues and then sam-
ples were freeze-dried again.
Analysis of the porosity and the microstructure of
scaffolds using micro-computed tomography. Scaffold
architecture was analyzed using micro-computed tomogra-
phy (l-CT) with a desktop micro CT scanner (SkyScan 1072,
Aartselaar, Belgium). No contrasting agent was added
and the samples had a minimum size of 4  4  2 mm3.
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The scanner was set at a voltage of 40 kV and a current of
248 A, and the samples were scanned at 8.71 lm pixel reso-
lutions by approximately 350 slices covering the sample
height of 2.5 mm. For imaging, the sliced 2D tomographic
raw images were reconstructed using CT Analyzer software,
and the threshold levels of the grayscale images were
equally adjusted for all the samples to allow the measure-
ment of the volume of pores, providing the data for scaffold
porosity. 3D modeling was also used to analyze the scaffold
structure in a nondestructive manner, using imaging
software.
Swelling tests
The extent of swelling was determined by a conventional
gravimetric procedure as reported in literature.31 Weighed
amounts of crosslinked CEL2/POL scaffolds (13 mm diame-
ter and 5 mm height, as measured by means of a caliber)
were kept in Phosphate Buffer Saline (PBS, Sigma, Italy) at
37C (pH ¼ 7.4). Swollen porous matrices were drawn at
various time intervals (6, 12, and 24 h), dried superﬁcially
by gentle contact with a ﬁlter paper and weighed for the
determination of wet weight as a function of the immersion
time.
The swelling percentage was calculated as
%Sw ¼ ðWs WiÞ=Wi½   100 (2)
where Wi and Ws are the sample weights before and after
swelling, respectively. Each test was repeated three times
for each composition and results were expressed as average
value 6 standard deviation.
Bioactivity evaluation
To study the bioactivity of samples, porous scaffolds (13
mm diameter and 5 mm height, as measured by means of a
caliber) were soaked in 5 mL of SBF prepared according to
the protocol described by Kokubo et al.,32 at 37C and pH
7.4 for various time intervals (2, 7, and 14 days, refresh of
solution once every 2 days). SBF has a composition similar
to human blood plasma and has been extensively used for
in vitro bioactivity test. At the end of each experiment, the
specimens were removed from SBF and then abundantly
rinsed with deionized water and freeze-dried for morpho-
logical analysis and compositional examination.
Mechanical characterization
The compressive strength of the scaffolds was measured
using a mechanical testing machine (MTS, QTest/10). Test
specimens were cylinder-shaped composite foams with 1.6
cm diameter and an average height of around 1–1.2 cm
measured by means of a caliber. Five porous samples were
evaluated for each composition. The samples were tested at
room temperature. The cross-head speed was set at 0.01
mms–1 and the load were applied until the specimen was
compressed to approximately 60% of its original length.
The compressive stress–strain curves were thus obtained
and the average compressive modulus with its standard
deviation was calculated for each sample. Precisely, the
modulus was determined as the slope of the initial linear
portion of the stress–strain curve.33
Furthermore, dynamic mechanical analysis (DMA) was
carried out on the prepared scaffolds to investigate their
behavior under cyclic compressive load. The scaffolds were
tested in a dry state; speciﬁcally, the samples underwent
dynamic compressive solicitation (load condition: sinusoi-
dally varying load of 110 mN superimposed to a static load
of 100 mN) at increasing frequencies varying from 0.1 to 40
Hz (DMA7 Perkin-Elmer analyzer). This frequency range is
typical for load-bearing conditions in physiological situa-
tions.34,35 Storage (E0) and loss (E00) modulus, that are the
real and imaginary component, respectively, of the complex
modulus E ¼ E0 þ iE00 (i ¼ ﬃﬃﬃﬃﬃﬃﬃ1p is the imaginary unit), were
recorded against frequency.36
In vitro culture
Human osteoblast-like cell line MG63 and human periosteal-
derived precursor cells (PCs) were used for in vitro tests
MG-63 human osteoblast-like cells (ATCC, Rockville, MD)
were grown in a controlled atmosphere (5% CO2; T¼37C)
in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM, Sigma-
Aldrich, Milan, Italy) supplemented with 10% fetal bovine
serum (FBS), 1% nonessential amino acids 2.0 mM L-gluta-
mine, and 1% penicillin–streptomycin (all from GIBCO, Invi-
trogen, Milan, Italy). After thawing, cells were routinely split
1:10 every 3–4 days and used between the third and fourth
passages
PCs cells were isolated from periosteal tissue of subjects
undergoing surgery for orthopedic trauma, after the obtain-
ment of their informed consent. Tissue was aseptically dis-
sected, washed three times in PBS, cut into small pieces
(2–3  2–3 mm), and placed into culture dish in Dulbecco’s
Modiﬁed Eagle Medium: Nutrient Mixture F-12 (DMEM/F12
GIBCO), supplemented with 10% FBS and 1% penicillin–
streptomycin (100 U/mL). The cells were then allowed to
adhere in standard cell culture conditions in a controlled
atmosphere (5% CO2; T ¼ 37C). The medium was changed
twice a week and cells were used between third and sixth
passage of subculture. To assess PCs mesenchymal stem
cells phenotype cells were characterized by FACSCalibur
ﬂow cytometry system (Becton Dickinson, CA,USA), using
antibodies against the following surface antigens: HLA-DR,
CD34, CD105, CD14, CD19, and CD45 (Diaclone, Besancon,
France); CD73 and CD90 (StemCell Technologies, Inc. Van-
couver, BC, and Canada).37
Cell seeding
Before seeding the freeze-dried CEL2/POL2 scaffolds were
disinfected in 70% ethyl alcohol solution (ETOH; Sigma-
Aldrich, Milan, Italy) for 2 h, washed two times in sterile
PBS (GIBCO) for 30 min and sterilized under UV 15 min for
each side. To improve cell adhesion, scaffolds were then
conditioned overnight in 10% serum added DMEM or
DMEM/F12 at 5% CO2, 37C. The medium was then dis-
carded and scaffolds considered ready for seeding. Cells
were detached using 0.25% trypsin in 1 mM ethylenediami-
netetraacetic acid (EDTA, Sigma-Aldrich, Milan; Italy) and
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seeded at a density of 1  104 cell/cm3 by applying 50 lL
of cell suspension on the samples placed in at 37C for 30
min in a humiﬁed chamber, to avoid the slip down of cells.
Then 1.5 mL of the appropriate culture media was added to
cover the samples placed in CorningVR ultra-low attachment
multiwell plates. Cells were cultured for 14 and 21 days.
Histology
Cultured scaffolds were ﬁxed in 4% paraformaldehyde in
0.1M phosphate buffer, pH 7.4, at 4C for 20 min and
washed three times with PBS and cut. Sections were taken
from the peripheral and the central part of the scaffold,
stained with 1 mg/mL 40, 6-diamidino-2-phenylindole (DAPI
D9542-Sigma-Aldrich) to stain cell nuclei, for 5 min at room
temperature. Fluorescence images were photographed using
a Zeiss AxioCam MRcs ﬂuorescence microscope (Carl Zeiss
Optical Inc., Germany) equipped with a Nikon DXM1200F
Ultra High-Quality Digital Camera (NITAL S.p.A., Turin,
Italy).
MTT (3-dimethylthiazol-2,5-diphenyltetrazolium
bromide) colorimetric assay
After incubation (14 and 21 days), the medium was
removed; 200 lL of MTT (Sigma, Milan, Italy) solution (5
mg/mL in DMEM without phenol red) and 1.8 mL of DMEM
were added to the cell monolayer; the multi-well plates
were incubated at 37C for further 4 h. After discarding the
supernatants, the dark blue Formosan crystals were dis-
solved by adding 2 mL of solvent (10% HCl 1N in isopropa-
nol, Sigma, Milan, Italy) and quantiﬁed spectrophotometri-
cally (Secomam, Anthelie light, version 3.8, Contardi, Italy)
at 570 and 690 nm. In the control cultures, the cells were
placed directly into adherent polystyrene culture plates at
the same culture density as placed onto the samples. The
mean and the standard deviations were obtained from three
different experiments of the same specimen.
Morphological and compositional characterization
(SEM-EDS)
Morphological analysis (SEM; Philips 525M) and composi-
tional analysis (EDS, Philips EDS 9100) were performed on
surfaces and fractured sections (in liquid nitrogen) of all
composite specimens. The samples were sputter coated
with silver prior to examination.
Samples from cell culture tests were ﬁxed in 2% glutar-
aldehyde (Sigma-Aldrich) in 0.1M cacodylate buffer (pH 7.4,
Sigma-Aldrich), post-ﬁxed in 1% osmium tetroxide (Sigma,
Milan, Italy), dehydrated in increasing ethanol (Sigma-
Aldrich) concentrations, CPD-dried, mounted on aluminum
stubs, gold-sputtered by the Edwards Sputter Coater B150S
equipment, and observed with a Philips XL 20 SEM (FEI Ita-
lia SRL, Milan, Italy) microscope.
Statistical Methods
All quantitative data were presented as mean 6 standard
deviation, unless otherwise noted. Statistical analysis was
carried out using single-factor analysis of variance (ANOVA).
A value of p < 0.05 was considered statistically signiﬁcant.
RESULTS AND DISCUSSION
Porosity and morphological analysis
The physical characteristics of a scaffold can be described
by the average pore size, pore size distribution, pore vol-
ume, pore interconnectivity, and pore shape. Porosity (%
vol) is deﬁned as the percentage of void space in a solid;38
it is a morphological property independent on the material.
Pores are necessary for bone tissue formation because they
allow migration and proliferation of osteoblasts and mesen-
chymal stem cells, as well as the proper vascularization of
the implant.39 In addition, a porous surface improves the
mechanical interlocking between the implant biomaterial
and the surrounding natural bone, providing greater me-
chanical stability at this critical interface.40 Optimal pore
diameters for 3D porous structures for bone repair are in
the 100–400 lm range,25 suitable for human osteoblast cell
penetration, and a minimum pore size is required for tissue
ingrowth,41 interconnectivity for access to nutrients and
transport of waste products and pore shape, and roughness
for better cell spreading.42
The porosity analysis within the scaffolds was deter-
mined by l-CT analysis. Pore distribution and 3D-recon-
struction of scaffolds are shown in Figure 1 and Table I.
The porosity was found to vary from 67.1 to 84.8% depend-
ing on the percentage addition of CEL2. In particular, the
total porosity decreased with increasing CEL2 amount
because the bioactive glass particles were deposited onto
the G/CH walls and they ﬁlled part of void space of G/CH
matrix, as conﬁrmed subsequently by SEM examination
[Fig. 2(b,c)]. A 3D representation of the scaffolds is shown
in Figure 1 and was used to calculate the pore size distribu-
tion. All results demonstrated that the scaffolds exhibited a
porous distribution with both macropores (size between 75
and 300 lm) and micropores (size 1–75 lm), which pres-
ence is crucial for protein and cell adhesion. Detailed analy-
sis indicated that 80% of pores within the resultant scaf-
folds had a pore size in the range of 75–300 lm. The mean
pore size was found to vary from 179.3 lm for CEL2/POL
0/100 scaffolds to 136.2 lm for CEL2/POL 70/30 compo-
sites. Moreover, in all composite porous matrices, a high
interconnected network of pores (about 95.6–97.5% by
l-CT analysis) was observed. Pore size may be controlled by
the temperature set in the freeze-drying process: pore diam-
eters increase with increasing temperature due to a higher
ice crystal growth rate.43 The pores within the scaffold arise
from the ice crystals that form during freezing of the G/CH
solution. This process forces the polymer to form aggregates
in the interstitial spaces and creates an interconnected net-
work of polymer ﬁbrils. A previous study has reported that
the pore size of a gelatin scaffold can be adjusted by alter-
ing the polymeric concentration, the freezing rate and the
pH value since these factors are known to affect both the
nucleation and the growth rate of the ice crystals.44 A
higher gelatin concentration and higher freezing rate of the
dispersion produced a lower porosity and smaller pores.
Higher porosity and larger pore sizes scaffolds could be
obtained by a lower polymeric concentration and low freez-
ing rate.
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It should be noted that the l-CT pore size analysis in
this study was performed on dry scaffolds. Generally, the
polymeric scaffold shrinks in the drying process. The scaf-
fold will expand when wetted in aqueous solution as
reported in the paragraph relative to swelling tests; so the
pore size in the wet condition will be larger than that
reported above.
SEM analysis was performed on selective portions of the
composite scaffolds to evaluate the effect of composition on
sample morphology. Figure 2 reports SEM images of the
fractured sections with the corresponding EDS spectra of
CEL2/POL scaffolds. Porous scaffolds showed a typical
foam-like morphology with interconnected pores with a
wide distribution of pore sizes and wall thickness. As it
can be observed in Figure 2, pore walls increased their
thickness with increasing CEL2 amount, which gave the
foams a more compact structure. For scaffolds containing
40 wt % of bioactive glass, CEL2 clusters of several microns
(60–80 lm) were observed, but in composites containing
70 wt % CEL2, the particles appeared more uniformly dis-
tributed. EDS spectra of G/CH scaffolds [Fig. 2(a)] showed
the characteristic elements of gelatin and chitosan: carbon
FIGURE 1. Pore distribution and 3D-reconstruction of (a) CEL2/POL 0/100 (b) CEL2/POL 40/60 (c) CEL2/POL 70/30 scaffolds as obtained by l-CT.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE I. Pore Data of CEL2/POL Scaffolds Obtained by l-CT
CEL2/POL
sample
Porosity
(%)
Pore
interconnectivity (%)
Mean pore
size (lm)
0/100 84.8 97.5 179.3
40/60 72.5 96.0 160.6
70/30 67.1 95.6 136.2
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(C), nitrogen (N), and oxygen (O) while EDS spectra of the
composites showed also the characteristic elements of
CEL2: silicon (Si), potassium (K), sodium (Na), magnesium
(Mg), calcium (Ca), and phosphorus (P) [Fig. 2(b,c)].
Swelling tests
One of the main factors to contribute to biocompatible na-
ture of biomaterials is the water content which imparts sev-
eral unique physiochemical properties to the material. A
polymer matrix imbibing an adequate amount of water
shows similar properties to living tissue-like membranes:
physiological stability, low interfacial tension, permeability
to biomolecules, etc.45 Moreover, swelling increases also the
pore size and total porosity, thus maximizing the internal
surface area of the scaffolds. Scaffolds showing higher
degree of swelling will have a larger surface area/volume
ratio thus allowing the porous matrices to have the maxi-
mum probability of cell infusion into the 3D scaffold as well
as maximum cell growth by attachment to the scaffold
surfaces. The increase in swelling also allows the scaffold to
avail nutrients from culture media more effectively. How-
ever, while the swelling would promote cell adhesion, it
could lower its mechanical properties. Thus for CEL2/POL
composites, the inﬂuence of chemical composition of the
composites on their water intake has been investigated.
Figure 3 reports the swelling degree as a function of time
for composite porous matrices with different compositions.
All composites showed a similar swelling behavior as a
function of time: swelling degree slightly increased as a
function of time from 6 to 24 h. CEL2/POL 0/100 scaffolds
displayed the maximum swelling degree at every time inter-
val. At 6 h, the swelling degree was about 884 6 47%,
while at 12 and 24 h the swelling ratio was 973 6 13%
and 1049 6 40%, respectively. For CEL2/POL 40/60 sam-
ples, at 6 h the swelling degree was about 568 6 29%. At
12 and 24 h, the swelling degree increased not signiﬁcantly.
Moreover, for CEL2/POL 70/30 composites, at 6 h swelling
ratio was about 259 6 50%, while at 12 and 24 h, the swel-
ling degree slightly increased.
At each time, swelling degree was found to decrease
with increasing CEL2 amount. The results were not surpris-
ing and were attributed to the lower hydrophilicity of the
inorganic phase as compared to the polymeric matrix: the
increase in the inorganic fraction of the composite resulted
in a decreased water sorption. In addition, the increasing
polymer-bioactive glass interaction with increasing concen-
tration of CEL2 resulted in a slower relaxation of polymer
chains, which also decreased the swelling ratio.
Bioactivity evaluation
An essential requirement for an artiﬁcial material showing
bioactivity is the formation of a biologically active bone-like
apatite on its surface when in contact with the physiological
environment. This property can be evaluated in vitro by
incubation in SBF. There is an oscillating phenomenon of
precipitation and dissolution processes in vitro, which is
due to metastable SBF. It was reported that the precipitation
and dissolution processes of bone like apatite take place
during the immersion of bioactive materials in SBF.
Hench reported that there is a good correlation of in vitro
FIGURE 2. SEM micrographs and EDS spectra of CEL2/POL scaffolds: fractured section of (a) CEL2/POL 0/100, (b) CEL2/POL 40/60, (c) CEL2/POL
70/30. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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bone-like apatite formation from SBF and in vivo bone-like
apatite (calcium phosphate) formation needed to secure
bone bonding.46 CEL2/POL composite scaffolds were inves-
tigated after immersion in SBF by SEM-EDS to check the
formation of an apatite layer onto the composite surface.
The interaction between the surface of the composites and
SBF solution may be responsible for the apatite nucleation.
Various bioactive ceramics such as TCP and BioglassV
R
have
been developed to be used clinically in bone repair.47 These
have been found to bond with bone through a layer of
bone-like apatite formed on the surface of the ceramics
when implanted into the body. This apatite has been charac-
terized as carbonate-containing HA and was not observed at
the interface between non-bioactive (or bio-inert) materials
and bone.48
Figure 4 reports SEM images with the corresponding
EDS spectra of the fractured section of CEL2/POL scaffolds
after soaking in SBF for 2, 7, and 14 days, respectively.
CEL2/POL 0/100 scaffolds did not induce the precipitation
of calcium phosphate crystals at any test time as shown in
Figure 4(a,d,g). As suggested by Cai and Kong.49,50 CH and G
are characterized by the lack of bioactivity, which severely
limits their biomedical applications; thus this feature needs
to be provided by the addition of biologically active materi-
als. For composite scaffolds, after 2 days of incubation in
FIGURE 3. Swelling behavior of scaffolds as a function of time. Data
are averaged on three measurements. Bars indicate standard devia-
tion (n ¼ 3).
FIGURE 4. SEM micrographs and EDS spectra of CEL2/POL scaffolds after immersion in SBF for different intervals: after 2 days (a) CEL2/POL 0/
100, (b) CEL2/POL 40/60, (c) CEL2/POL 70/30, after 7 days (d) CEL2/POL 0/100, (e) CEL2/POL 40/60, (f) CEL2/POL 70/30, and after 14 days (g) CEL2/
POL 0/100, (h) CEL2/POL 40/60, (i) CEL2/POL 70/30 (bar 100 lm). [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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SBF, small amount of calcium phosphate crystals were
observed as shown in Figure 4(b,c) (SEM image and EDS
spectra). After 7 days of incubation, substantial amount of
apatite microparticles with a diameter up to 2–4 lm were
formed on the surface of the pore walls of the composite
scaffolds [Fig. 4(e,f)]. After 14 days of incubation, the whole
pores of CEL2/POL 40/60 and 70/30 composites were
entirely covered by a layer of apatite [Fig. 4(h,i)]. Further-
more, the EDS spectra displayed the presence of small
amounts of Mg, Si, Na, and K ions incorporated in the min-
eral phases, due to the remaining CEL2. In conclusion, an
increasing incubation time of the composite scaffolds in SBF
(from 2 to 14 days) led to the formation of a higher amount
of apatite. However, the interconnected macroporous struc-
ture of the scaffolds was maintained, which is important for
cell migration and mass transport when the scaffolds is
implanted in vivo. Moreover, after 14 days of immersion in
SBF, EDS spectra recorded from the samples covered with
the inorganic aggregates deposited on CEL2/POL scaffolds
after SBF tests [Fig. 4(h,i)] allowed the calculation of Ca/P
molar ratio which resulted in 1.58 and 1.61 for CEL2/POL
40/60 and 70/30, respectively. These values are very close
to the stoichiometric Ca:P value of hydroxyapatite (1.67).51
Figure 5 shows the magniﬁcation of SEM micrographs rela-
tive to CEL2/POL 40/60 and 70/30 composites after 14
days of SBF immersion. The results indicate that the
increasing addition of CEL2 enhances the bioactivity of com-
posite scaffolds containing chitosan/gelatin as the organic
phase. The mechanism of apatite formation in SBF was
described by several researchers.52,53 It was reported that
the formation of apatite on artiﬁcial materials is induced by
functional groups which could reveal negative charge and
further induce apatite deposition via the formation of amor-
phous calcium phosphate. In this research, the major reason
for the enhancement of apatite formation on the composite
scaffolds might be the bioactive glass particles acting as
FIGURE 5. SEM micrograph magnifications of CEL2/POL scaffolds after immersion in SBF for 14 days: (a) CEL2/POL 40/60 and (b) CEL2/POL 70/30.
FIGURE 6. Stress–strain curves of the porous composite scaffolds
compressed at a strain of (0–60%). The cross-head speed was 0.01
mms–1. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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nucleation initiation sites. In fact, CEL2 is a highly bioactive
glass and the ability of CEL2 to induce the precipitation of
HA (both as a macroporous scaffolds and as a ﬁller in gela-
tin ﬁlms) has been previously documented.54,55 An increas-
ing amount of CEL2 in the composite scaffolds was associ-
ated with the presence of a higher density of nucleation
sites for HA, and as a result a higher amount of apatite
could be deposited at each time. Once the apatite nuclei
have been formed, they can grow spontaneously by consum-
ing the calcium and phosphate ions present in the sur-
rounding ﬂuid.
Mechanical characterization
One of the major critical point in developing load-bearing
scaffolds for bone tissue engineering is the conﬂicting
requirement of scaffolds with high porosity and mechanical
strength. A highly porous structure is preferred in favor of
cell growth and proliferation, but it is generally achieved at
the expense of mechanical strength. In the scientiﬁc litera-
ture, compressive strength of substrates has often been
found to decrease with increasing pore size.56 The mechani-
cal properties of the porous composite scaffolds in terms of
compressive strength were tested using a mechanical testing
machine. The force was analyzed from stress–strain data
obtained under a compressive load at a constant speed.
Figure 6 shows the stress–strain curves obtained for the
porous composite scaffolds by the excessive compression
test at strain of 0–60%. During the test, the composites did
not show a ﬁnal fracture; rather, they underwent densiﬁca-
tion. The curves were classiﬁed in three distinct regions: lin-
ear elastic, collapse plateau, and densiﬁcation regimes as
reported in.57 The values of elastic modulus (E*), collapse
strength, and strain (r* and e*, respectively), and collapse
modulus (Dr/De) were calculated from the curves are listed
in Table II. A signiﬁcant increase of compression Young’s
modulus was obtained by adding inorganic phase into the
polymeric matrix, due to the superior compression behavior
of CEL2 as compared to POL phase. As shown in Figure 6
and in Table II, the collapse strength and collapse strain
were characterized by a different trend as a function of the
CEL2 amount. In particular, the increase of the inorganic
phase caused a progressive slight decrease in the deform-
ability of the composite scaffold and an increase of the col-
lapse strength and collapse modulus.
It is generally accepted that the scaffolding material for
bone tissue engineering should have mechanical strength as
close as possible to the strength of the bone to be repaired
or substituted. In this study, a compressive modulus of 2.1
MPa was obtained for CEL2/POL 70/30 scaffold by adjust-
ing processing conditions to achieve a highly densiﬁed
porous structure. The obtained scaffolds, containing 70 wt
% CEL2, had a compression Young’s modulus comparable to
the modulus of alveolar bone.58 Moreover, the composite
matrices are expected to be suitable candidates for the
articular cartilage/subchondral bone regeneration. As
described above, a graded biomimetic osteochondral com-
posite scaffold is necessary. Different methods were
reported in literature to prepare bi-layered scaffolds,59–61
generally based on two consecutive different procedures
(e.g. sintering and freeze-drying). In our case, graded scaf-
folds could be easily obtained by casting the mixture solu-
tions before gelling: the lower water solubility and higher
density of CEL2 as compared to the polymeric phase caused
the progressive precipitation of CEL2 at the bottom of Petri
dishes during solvent evaporation.
Both storage and loss modulus (E0 and E00) were meas-
ured in the frequency range 0.1–40 Hz, which are typical
frequencies found in physiological situations in load-bearing
applications.62 The storage modulus (E0) is about one order
of magnitude higher than the loss modulus (E00) indicating
an elastic nature of the scaffolds. The storage and loss mod-
ulus behavior as a function of the frequency of the loading
cycle is reported in Figure 7(a,b). The trend of both moduli
is quite similar in each single scaffolds batch (CEL2/POL 0/
100, CEL2/POL 40/60, or CEL2/POL 70/30), whereas the
behavior differs in the case of different series (wholly
polymeric or composite samples). As regards the wholly
polymeric scaffolds, storage and loss modulus remained
roughly constant at low (below 1 Hz) and mid (1–10 Hz)
frequencies, and showed an increase for higher frequencies.
On the contrary, composite scaffolds (CEL2/POL 40/60 and
CEL2/POL 70/30) are characterized by a more complex
behavior, and the corresponding curves plotted in Figure
7(a,b) can be divided into three distinct regions. At low fre-
quencies (below 1 Hz), both storage and loss modulus of
porous composites increased with increasing frequency;
afterward, there was a drop of E0 and E00 around 1 Hz, and
for higher frequencies both moduli increased again. there is
an increase in E00 for high frequencies, which suggests that
the material exhibits some dissipation capability for high
frequencies. Moreover, it is worth to underline that the stor-
age modulus is about one order of magnitude higher than
the loss modulus, which indicates the predominantly elastic
nature of the prepared composite scaffolds in dry state.
Although the Young’s modulus, which was calculated from
the slope of the initial part of the stress–strain curve, can
be considered conceptually similar to the storage modulus,
they could not be directly compared as the latter one is de-
pendent on frequency. However, according to Malafaya
et al.,63 we considered E0 and E00 acquired at a frequency of
TABLE II. Elastic Modulus, Collapse Strength and Strain, and Collapse Modulus Calculated from the Corresponding Stress–
Strain Curves
CEL2/POL sample E* (kPa) r* (kPa) e* (%) Dr/De (kPa)
0/100 1227.2 6 116.4 203.5 6 21.8 21.7 6 3.0 203.7 6 41.2
40/60 1403.0 6 111.2 214.1 6 6.4 19.9 6 2.1 350.1 6 38.2
70/30 2120.6 6 106.9 374.0 6 7.1 17.5 6 2.1 737.2 6 38.6
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1 Hz as reference values for purpose of comparison
(Table III). These values of storage modulus are comparable,
as order of magnitude, to those of Young’s modulus
acquired under static conditions for all the three scaffold
batches.
The loss factor tan d ¼ E00=E0, measuring the ability of
dissipating the cyclic mechanical energy in form of heat, is
plotted in Figure 7(c). Composite scaffolds show a remark-
able dissipation ability, related to damping properties, espe-
cially at low and high frequencies, which can be a very use-
ful feature in view of in vivo implantation.
Investigation of the mechanical properties of glass/
polymer scaffolds by DMA is new with respect to previous
literature. However, we cannot ignore that the results
presented in this work represents a preliminary achieve-
ment, as the samples were tested in dry state; more accu-
rate data could come from DMA on the composite scaffolds
in wet state, to better mimic the physiological conditions in
which the materials will be potentially used.
TABLE III. Mean Values of Storage (E0) and Loss (E00)
Modulus of the Different Scaffolds Series Acquired at a
Frequency of 1 Hz
CEL2/POL sample E0 (kPa) E00 (kPa)
0/100 920 180
40/60 1768 295
70/30 3220 916
FIGURE 8. Section of the central part of CEL2/POL 30/70 scaffold that
evidenced the presence of MG63 stained with DAPI (blue). [Color fig-
ure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 7. Dynamic mechanical analysis of CEL2/POL scaffolds show-
ing: (a) the storage (E 0), (b) loss (E00) modulus behavior, and (c) the
loss factor (tan d) for increasing frequencies under dynamic compres-
sion solicitation.
FIGURE 9. Histogram of MTT test performed on MG63 (a) and PCs
(b) cultured on CEL2/POL 100/0, 40/60, and 30/70 for 14 and 21 days.
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Cell compatibility
Overall, cells displayed a good ability to interact with the
different tested scaffolds which did not modify cell meta-
bolic activity at the analyzed points (i.e. 14 and 21 days).
Histological sections stained with DAPI demonstrated the
presence of a small amount of cells in the central part of
the scaffold (Fig. 8).
Comparing the data obtained at 14 and 21 days of cul-
ture, MTT test proved only a slight difference between the
two cytotypes analyzed (Fig. 9). On CEL2/POL 0/100, an
increase in cell proliferation was observed only for PCs
while no changes were detected for MG63. A signiﬁcant
(p < 0.01) increase in cell proliferation for both cell cyto-
types cultured on CEL2/POL 40/60. Interestingly, while no
differences were detected in MG63 cultured on CEL2/POL
70/30 a signiﬁcant (p < 0.01) reduction of this parameter
was detected for PCs.
SEM observations of PCs cultured on the different scaf-
folds were consistent with MTT data, showing changes in
cell morphology (Figs. 10 and 11). At 14 days of culture,
cells on CEL2/POL 0/100 were elongated forming a uniform
sheet on the scaffolds’ surface [Fig. 10(a,d)]. At 21 days,
cells resulted more spreaded and tried to grow inside pores
[Fig. 11(a,d)]. On CEL2/POL 40/60 [Figs. 10(b) and 11(b)]
cells were elongated and less uniformly distributed in com-
parison with CEL2/POL 0/100. This phenomenon may be at
least in part related to not uniform surface of the scaffold
that hampered initial cell adhesion and, consequently, cell
proliferation. The reduced cell density was more evident on
CEL2/POL 70/30, which were the scaffolds with the most
uneven surface. On these scaffolds, cells displayed a more
irregular morphology that stretched out to cross scaffold
macroporosity [Fig. 10(c,f)]. This irregular star-shaped as-
pect was maintained also at 21 days of culture [Fig. 11(c,f)],
suggesting that different chemical composition, affecting
scaffold macro- and microstructure and stiffness, could
inﬂuence cell differentiation,64,65 as already shown in our
previous work.66 Cell proliferation decreases as differentia-
tion signs increased. In this respect, our results suggest that
scaffolds with an increased amount of inorganic phase (i.e.
CEL2/POL 70/30) may stimulate PCs differentiation into an
osteoblastic progeny. In contrast, MG-63 cells appear to
hold different cross-talks with the different tested scaffolds
than PCs. These cells are immortalized, immature and have
a high proliferative potential that probably slow down their
differentiation capability without any additional treatment.
CONCLUSIONS
Freeze-dried CEL2/POL scaffolds (0/100; 40/60; 70/30 wt
%/wt) showed an interconnected network of macropores
with 100–200 lm average size as shown by SEM and l-CT
analysis. As the amount of CEL2 increased, the total porosity
FIGURE 10. SEM observation of PCs cultured for 14 days on CEL2/POL 100/0 (a,d), CEL2/POL 40/60 (b,e), and CEL2/POL 30/70 (c,f). Scale bar a–c
100 lm; scale bar d–f 20 lm.
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and the mean pore size slightly decreased because the bioac-
tive glass particles deposited onto the polymeric pore walls
and ﬁlled part of the void space of the matrix. Furthermore,
composites containing CEL2 were particularly interesting due
to their stability in aqueous solution as evidenced by swel-
ling tests and to their pronounced bioactivity and expected
consequent bone-bonding ability during in vivo trials. In fact,
they are expected to react with physiological ﬂuids, forming
hydroxyapatite layers on the ﬁlm surface containing inor-
ganic phase and creating strong bonds to hard and soft tis-
sues through cellular activity. As evidenced by SBF immer-
sion tests, an increasing CEL2 amount greatly enhanced the
bioactivity of the scaffold: glass particles behaved as nuclea-
tion sites for apatite crystallization. The elastic modulus of
the composites with the highest glass content (70 wt %) was
found to be comparable to that of alveolar bone. DMA carried
out on the composite scaffolds in dry state shows that the
samples exhibit a remarkable dissipation ability especially at
low and high frequencies; this damping effect could be a use-
ful feature in view of in vivo implantation.
Additional work is in progress to increase the mechani-
cal resistance of the scaffolds by the substitution of gelatin
with collagen in the organic phase and the use of combined
crosslinking techniques and/or blending strategies with the
aim to extend the application of CEL2-based composites to
the repair of other bone defects.
Morphological and biochemical analysis performed with
a continuous cell line (MG63) and with human periosteal-
derived stem cells seeded on the CEL2/POL scaffolds
showed that cells maintain their metabolic activity and abil-
ity to proliferate on the scaffold. Differentiation and over
proliferation occurred to PCs, at the increase of bioactive
glass concentration, reveal the capacity of tested scaffold to
modulate osteogenic properties.
Therefore, the proposed scaffolds, which are resorbable,
bioactive, and capable to modulate cell proliferation/
differentiation processes, may be interesting tools in osteo-
chondral tissue regeneration. Further studies are in progress
to validate this hypothesis.
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